US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 17, 2016 (10 years ago)

Sulfacetamide Sodium Ophthalmic Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility; some lots failed Antimicrobial Effectiveness Testing on stability

What was recalled

Sulfacetamide Sodium Ophthalmic Solution, USP, 10%, Sterile, Rx Only, 15 mL bottles, Mfd. by: Akorn, Inc., Lake Forest, IL 60045 --- NDC 17478-221-12

Recalling firm
Akorn, Inc.
NDC code
17478-221-12
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0949-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sulfacetamide recalls

See all
Class III · Low risk Terminated

Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads

Reason Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.

Acella Pharmaceuticals, LLC NDC 42192-113-60 D-0074-2023
Class II · Moderate risk Terminated

CSF Otic Insufflation Capsule

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1633-05 D-0431-2022
Class III · Low risk Terminated

Sodium Sulfacetamide

Reason Subpotency: one product for active ingredient assay and another one for preservative assay

Monarch PCM, LLC NDC 42808-103-06 D-0817-2021